Cardlytics (CDLX) Reports Acquisition of Dosh for $275M in Cash and Shares
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 9/28/2026
- Wall St declines as oil spikes after Trump rejects Iran peace proposal
- S&P 500 breadth hits lowest level since dot-com bubble, Goldman says
- Nvidia’s AI dominance funds historic $150 billion buyback
- MongoDB stock drops 15% as CEO Desai resigns for Meta
- Jefferies cuts Roblox to Underperform, says rally is too optimistic
- Bloom Energy shares fall on Oracle project halt
- Oppenheimer sees AI software winners as focus shifts to ROI
- Exclusive-Activist Jana pushes Fiserv to accelerate cost cuts and tap Palantir
- Cantor Fitzgerald Starts Lexicon Pharmaceuticals (LXRX) at Overweight
- Accenture (ACN) call put ratio 1 call to 1.2 puts into quarter results
Cardlytics (CDLX) Prices 3.85M Share Common Offering at $130/Sh
March 3, 2021 6:11 AM ESTCardlytics, Inc. (NASDAQ: CDLX) today announced the pricing of an underwritten public offering of 3,850,000 shares of its common stock, at a price to the public of $130.00 per share. The gross proceeds to Cardlytics from the offering, before deducting underwriting discounts and commissions and... More
Cardlytics (CDLX) Misses Q4 EPS by 2c, Revenues Beat; Offers FY21 Revenues Mid-Point Guidance Above Consensus
March 1, 2021 6:43 AM ESTCardlytics (NASDAQ: CDLX) reported Q4 EPS of ($0.05), $0.02 worse than the analyst estimate of ($0.03). Revenue for the quarter came in at $67.1 million versus the consensus estimate of $60.89 million.
Fourth Quarter 2020 Financial Results
Total revenue was $67.1 million, a decrease of (3.2)%, compared to $69.3 million in the fourth quarter of 2019.Net loss attributable to common stockholders was $(6.8) million, or $(0.24) per diluted share, based on 27.7 million weighted-average common shares outstanding, compared to a net income attributable to common stockholders of $3.4 million, or $0.12 per diluted... More